Marcia Belvin - SVP, Chief Scientific Officer at CytomX Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Scientific Officer
Stock Symbol
CTMX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Marcia Belvin - trading volume in the past year for CytomX Therapeutics, Inc.

Holdings reported by Marcia Belvin for CytomX Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 272K $732K $2.69 Jun 16, 2025 Direct
Performance Stock Units (PSUs) 18.2K $0 $1.23 Sep 26, 2025 Direct Common Stock
Stock Option (Right to Buy) 36.3K Sep 26, 2025 Direct Common Stock
Performance Stock Units 0 Jun 13, 2025 Direct Common Stock

Transactions reported by Marcia Belvin for CytomX Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.